With regard to the substances listed in Annex III, the Commission shall seek additional information, taking into account recent scientific data from all possible sources, and keep the measures applied under regular review with a view to the timely presentation to the European Parliament and to the Council of any necessary proposals.
Art. 11a Directive (EU) 1996/22
I henhold til artikel 11a i direktiv 96/22/EF skulle Kommissionen senest den 14. oktober 2005 aflægge rapport om, hvorvidt der findes alternative veterinærlægemidler til dem, der indeholder østradiol 17 β, til behandling af dyr …
Changed on 18 Dec 2008
The Commission shall present within two years from 14 October 2003 to the European Parliament and to the Council, a report on the availability of alternative veterinary medicinal products to those containing oestradiol 17β or its ester-like derivatives for the treatment of foetus maceration or mummification in cattle, and for the treatment of pyometra in cattle, and present to them the following year any necessary proposals intending to replace these substances in due time.
Likewise, with With regard to the substances listed in Annex III, the Commission shall seek additional information, taking into account recent scientific data from all possible sources, and keep the measures applied under regular review witha with a view to the timely presentation to the European Parliament and to the Council of any necessary proposals.
- 18 Dec 2008 – todayin force
- 14 Oct 2003 – 18 Dec 2008earlier wording
Versions are held from 29 Apr 1996; the article may be older.